Pheiron: Funding, Investors & Team (Sep 2026)
Pheiron offers a platform that is scalable, secure, and interoperable for managing health data using advanced analytics. The company's main focus is on increasing the chances of success in drug development by utilizing causal insights on targets and populations. Pheiron employs artificial intelligence to analyze various types of data related to diseases, with the goal of improving understanding and informing decisions in the drug development process. Additionally, the platform enables large-scale analysis of exome sequences to identify factors specific to sex and age in health management.
Pheiron has raised $4.2M across 1 funding round on record, the most recent an undisclosed round of $4.2M announced in Jun 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Pheiron Company Profile and Key Stats
Latest funding round on record: Jun 2025.
Pheiron Funding Rounds
Pheiron Founders and Leadership Team
Contact details for the Pheiron team: 1 of 1 has an email address on file.
Start 14-day free trial →Pheiron Funding Compared to Other Biotechnology Startups
Pheiron's latest round of $4.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Pheiron in Biotechnology and Berlin
Companies Similar to Pheiron
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug…
Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of…
NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and…
Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is…
Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and…
Mbiomics is a company in the field of biotechnology.
At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their…
Picea Biosolutions is a biotechnology firm. Based on their core platform technology, they develop tailored…
KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity.…
Pheiron Funding FAQs
What does Pheiron do?
Pheiron offers a platform that is scalable, secure, and interoperable for managing health data using advanced analytics. The company's main focus is on increasing the chances of success in drug development by utilizing causal insights on targets and populations. Pheiron employs artificial intelligence to analyze various types of data related to diseases, with the goal of improving understanding and informing decisions in the drug development process. Additionally, the platform enables large-scale analysis of exome sequences to identify factors specific to sex and age in health management.
How much funding has Pheiron raised?
Pheiron has raised $4.2M across 1 round on record. The most recent is an undisclosed round of $4.2M announced in Jun 2025.
When did Pheiron last raise funding?
Pheiron's most recent funding round on record is an undisclosed round of $4.2M, announced in Jun 2025.
Who founded Pheiron?
FundedIQ lists Jakob Steinfeldt (Founder) at Pheiron.
Where is Pheiron headquartered?
Pheiron is based in Berlin, Germany.
How many employees does Pheiron have?
Pheiron is in the 1-10 employee band.
How does Pheiron's funding compare to other Biotechnology startups?
Pheiron's latest round of $4.2M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Pheiron Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pheiron is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.